Pharmacokinetic, Safety and Immunogenicity Study of CMAB809 and Herceptin in Healthy Volunteers
Clinical trial NCT04049409 · COMPLETED
Trial details
- NCT number
- NCT04049409
- Sponsor
- Taizhou Mabtech Pharmaceutical Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2019-11-20
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.